2023-07-19T00:51:10Z
ENA-FIRST-PUBLIC
2023-07-19T00:51:10Z
ENA-LAST-UPDATE
SAMN31740217
External Id
GSM6732481
External Id
2023-07-19T00:51:10Z
INSDC first public
2023-07-19T00:51:10Z
INSDC last update
public
INSDC status
SRS15765564
SRA accession
GSM6732481
Submitter Id
NCBI
broker name
Expanded TIL
cell line
CD4+CD8+
cell type
missing
collection_date
human
common name
female
gender
missing
geo_loc_name
37%
infusion percent_cd4
63%
infusion percent_cd8
3.11E+10
number til_infused
Homo sapiens
organism
10
overall survival_months
1
pfs censor_at_12_months
5
pfs months
PR
response
Homo sapiens
scientific_name
TIL ACT Product
source_name
1
survival censor
TIL ACT Product
tissue
Patient 21 CD4+CD8+ [Pt21_DP RNA-seq]
title
TIL ACT
treatment
16992
trial